Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The food dye FD&C Blue No. 1 (Brilliant Blue FCF [BB FCF]) is structurally similar to the purinergic receptor antagonist Brilliant Blue G (BBG), which is a well-known inhibitor of the ionotropic P2X7 receptor (P2X7R). The P2X7R functionally interacts with the membrane channel protein pannexin 1 (Panx1) in inflammasome signaling. Intriguingly, ligands to the P2X7R, regardless of whether they are acting as agonists or antagonists at the receptor, inhibit Panx1 channels. Thus, because both P2X7R and Panx1 are inhibited by BBG, the diagnostic value of the drug is limited. Here, we show that the food dye BB FCF is a selective inhibitor of Panx1 channels, with an IC50 of 0.27 µM. No significant effect was observed with concentrations as high as 100 µM of BB FCF on P2X7R. Differing by just one hydroxyl group from BB FCF, the food dye FD&C Green No. 3 exhibited similar selective inhibition of Panx1 channels. A reverse selectivity was observed for the P2X7R antagonist, oxidized ATP, which in contrast to other P2X7R antagonists had no significant inhibitory effect on Panx1 channels. Based on its selective action, BB FCF can be added to the repertoire of drugs to study the physiology of Panx1 channels. Furthermore, because Panx1 channels appear to be involved directly or indirectly through P2X7Rs in several disorders, BB FCF and derivatives of this "safe" food dye should be given serious consideration for pharmacological intervention of conditions such as acute Crohn's disease, stroke, and injuries to the central nervous system.
Figure 1. BzATP- induced currents in oocytes expressing the human P2X7R. The membrane potential was clamped at â60 mV, and brief 10-mV pulses were applied at a rate of 0.1 Hz for assessment of changes in membrane conductance. The currents and conductance changes induced by 100 µM BzATP were either sustained (A) or diminished (B) over time, despite the presence of the stimulant depending on the batch of oocytes. BzATP-induced currents in oocytes were inhibited by BBG but not by BB FCF (CâE). Experimental conditions were the same as in A, except the inhibitors BB FCF and BBG were included. (C) In the presence of 100 µM BB FCF, membrane currents of significant amplitude were induced by BzATP, which were attenuated by 10 µM BBG. (D) When applied in the presence of BzATP, the induced currents were minimally affected by 100 µM BB FCF. (E) Quantitative analysis of membrane currents induced by BzATP in the presence of 100 µM BB FCF or of various concentrations of BBG. Means ± SD are plotted, and n is indicated.
Figure 2. Dose-dependent inhibition of Panx1 currents by BB FCF. The membrane potential was clamped at â60 mV, and brief +60-mV pulses were applied at a rate of 0.1 Hz to open Panx1 channels. (A) BB FCF attenuated the Panx1-mediated currents in a dose-dependent fashion. (B) Doseâresponse relationship of inhibition of membrane currents by BB FCF. Means ± SD (n = 4) are plotted. (C) Uninjected control oocytes subjected to the same pulse protocol exhibited small currents unaffected by 10 µM BB FCF and by 10 µM Fast Green FCF.
Figure 3. PubChem structures of dyes used in this study. The food dyes BB FCF and Fast Green FCF are structurally identical except for one OH group. BBG is structurally related to the food dyes but exhibits clear differences.
Figure 4. KGlu-induced ATP release from oocytes expressing Panx1 was inhibited by BB FCF. ATP release was determined with the luciferase assay, with which the dye interferes. A correction factor for this interference was determined and used for plotting the data.
Figure 5. Failure of BB FCF to affect connexin channels. Two connexins, Cx32E143 and Cx46, forming open âhemichannelsâ at regular calcium ion concentrations in oocytes expressing them, were tested. The membrane potential was clamped at â50 mV, and brief pulses to 0 mV were applied at a rate of 0.1 Hz to open the connexin channels. 100 µM BB FCF did not affect the currents carried by either connexin. The traces are representative of four trials for each connexin on different oocytes.
Figure 6. Effect of various Panx1 inhibitors in alanine replacement mutants lacking the feedback inhibition by ATP. The Panx1 inhibitors carbenoxolone, BB FCF, Fast Green FCF, and probenecid were tested in wild-type Panx1 and various alanine replacement mutants using the same protocol as in Fig. 2. The inhibition by probenecid was almost abolished in Panx1 W74A. Carbenoxolone and Fast Green FCF inhibited the currents effectively in all mutants. BB FCF inhibition was attenuated in all mutants except Panx1 I247A. Means ± SD are plotted. n = 5 for Panx1 I247A and L266A, and n = 4 for all other points.
Figure 7. Effect of oATP on Panx1 currents and P2X7R-mediated currents induced by 100 µM BzATP. con, voltage-induced Pannx1 currents or BzATP-induced P2X7R currents in the absence of oATP. Oocytes expressing Panx1 or P2X7R were preincubated with 100 µM oATP for 2â3 h before measurements of membrane currents. oATP only attenuated BzATP-induced currents in P2X7R-expressing oocytes. Means ± SD are plotted, and n is indicated.
Anderson,
ATP-induced ATP release from astrocytes.
2004, Pubmed
Anderson,
ATP-induced ATP release from astrocytes.
2004,
Pubmed
Arbeloa,
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
2012,
Pubmed
Bao,
Pannexin membrane channels are mechanosensitive conduits for ATP.
2004,
Pubmed
,
Xenbase
Borzelleca,
Lifetime toxicity/carcinogenicity studies of FD & C Blue No. 1 (brilliant blue FCF) in rats and mice.
1990,
Pubmed
Bruzzone,
Pannexins, a family of gap junction proteins expressed in brain.
2003,
Pubmed
,
Xenbase
Chaumont,
Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels.
2008,
Pubmed
Chu,
Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus.
2012,
Pubmed
Dahl,
Pannexin: from discovery to bedside in 11±4 years?
2012,
Pubmed
Dahl,
Mutagenesis to study channel structure.
2001,
Pubmed
,
Xenbase
Díaz-Hernández,
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.
2009,
Pubmed
Flury,
Brilliant Blue FCF as a Dye Tracer for Solute Transport Studies-A Toxicological Overview.
1994,
Pubmed
Gulbransen,
Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis.
2012,
Pubmed
Iglesias,
Pannexin 1: the molecular substrate of astrocyte "hemichannels".
2009,
Pubmed
Iriyama,
Effect of Brilliant Blue G on the retinal ganglion cells of rats.
2012,
Pubmed
Iwamaru,
Anti-prion activity of Brilliant Blue G.
2012,
Pubmed
Jiang,
Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors.
2000,
Pubmed
Jo,
Inhibition of neuronal voltage-gated sodium channels by brilliant blue G.
2011,
Pubmed
Kimbler,
Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice.
2012,
Pubmed
Locovei,
Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex.
2007,
Pubmed
,
Xenbase
Locovei,
Pannexin 1 in erythrocytes: function without a gap.
2006,
Pubmed
,
Xenbase
Lopatář,
Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
2011,
Pubmed
North,
Molecular physiology of P2X receptors.
2002,
Pubmed
North,
Nucleotide receptors.
1997,
Pubmed
Pelegrin,
Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor.
2006,
Pubmed
Peng,
Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.
2009,
Pubmed
Penuela,
Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype.
2012,
Pubmed
Pfahnl,
A chimeric connexin forming gap junction hemichannels.
1997,
Pubmed
,
Xenbase
Qiu,
Alanine substitution scanning of pannexin1 reveals amino acid residues mediating ATP sensitivity.
2012,
Pubmed
Qiu,
A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP.
2009,
Pubmed
,
Xenbase
Qu,
Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation.
2011,
Pubmed
Ransford,
Pannexin 1 contributes to ATP release in airway epithelia.
2009,
Pubmed
,
Xenbase
Santiago,
Targeting pannexin1 improves seizure outcome.
2011,
Pubmed
Séror,
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.
2011,
Pubmed
Silverman,
The pannexin 1 channel activates the inflammasome in neurons and astrocytes.
2009,
Pubmed
,
Xenbase
Suadicani,
ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes.
2012,
Pubmed
Takenouchi,
P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
2010,
Pubmed
Thompson,
Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus.
2008,
Pubmed
Thompson,
Ischemia opens neuronal gap junction hemichannels.
2006,
Pubmed
Traini,
P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase 1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro.
2011,
Pubmed
Wang,
SCAM analysis of Panx1 suggests a peculiar pore structure.
2010,
Pubmed
,
Xenbase